Amrize (NYSE:AMRZ) Now Covered by Barclays

Barclays began coverage on shares of Amrize (NYSE:AMRZ) in a research note issued to investors on Tuesday,Benzinga reports. The brokerage set an “equal weight” rating on the stock.

AMRZ has been the subject of a number of other research reports. Royal Bank Of Canada lowered their target price on Amrize from $61.00 to $54.00 and set an “outperform” rating for the company in a report on Friday, August 8th. Oppenheimer started coverage on Amrize in a report on Tuesday, September 9th. They set an “outperform” rating and a $62.00 price objective for the company. Zacks Research cut Amrize from a “hold” rating to a “strong sell” rating in a research note on Wednesday, August 27th. JPMorgan Chase & Co. raised their price target on shares of Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 26th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Amrize in a report on Saturday, September 27th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $58.67.

Amrize Trading Down 0.7%

Shares of AMRZ opened at $48.38 on Tuesday. The company has a 50 day simple moving average of $51.00. Amrize has a 52-week low of $44.12 and a 52-week high of $56.29. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.38 and a quick ratio of 0.85.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.03 by ($0.25).

Insider Activity at Amrize

In other news, insider Stephen S. Clark bought 5,000 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were bought at an average cost of $51.82 per share, with a total value of $259,100.00. Following the acquisition, the insider owned 5,000 shares in the company, valued at $259,100. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Mario Gross bought 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The stock was purchased at an average price of $49.63 per share, with a total value of $148,890.00. Following the completion of the purchase, the insider directly owned 23,232 shares in the company, valued at $1,153,004.16. The trade was a 14.83% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 1,124,000 shares of company stock worth $53,225,260 over the last ninety days.

Institutional Investors Weigh In On Amrize

A number of large investors have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets acquired a new position in shares of Amrize in the second quarter valued at $59,000. Groupe la Francaise bought a new stake in shares of Amrize during the 2nd quarter worth about $60,000. Allianz SE acquired a new position in Amrize in the 2nd quarter valued at about $80,000. Osaic Holdings Inc. bought a new position in Amrize in the 2nd quarter valued at about $90,000. Finally, Credit Industriel ET Commercial acquired a new stake in Amrize during the second quarter worth approximately $109,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.